³ÉÈË´óƬ Vice-Principal ResearchNews
Industry, Academia and Investment
Date Published: Nov 24, 2022
Most recently, Queen’s took part in the first-ever Hub350 Annual Partner Summit in Kanata, which brought together industry, financial and academic partners to celebrate and strengthen existing collaborations and build new connections
November 15, 2022: U.S. Patent No. 11,498,853 "Water with Switchable Ionic Strength"
Date Published: Nov 15, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,498,853
Wings graduate Nephron.Health looking to help kidney disease patients
Date Published: Nov 15, 2022
For Nephron.Health, the business is more than just a passion project – the team is living the experiences themselves.
mDETECT getting ready to commercialize important cancer detection method
Date Published: Nov 10, 2022
A Queen’s research discovery has the potential to become a game-changer for breast cancer diagnosis and treatment.
Queen’s Professor Stephen Archer's technology has multiple treatment applications
Date Published: Nov 08, 2022
Professor Stephen Archer and his colleagues, Dr. Danchen Wu and Dr. Michael Wells, have developed an enzyme inhibitor and early research suggests that it may be very effective in fighting cancer, Alzheimer’s disease, pulmonary hypertension.